Healing effect of Pilocarpine gel 4% on skin lesions of pemphigus vulgaris

International Journal of Dermatology

Volumn 45, Issue 6, 2006, Pages 743-746

  Iraji, Fariba ^a   Yoosefi, AliReza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; PILOCARPINE; PLACEBO; PREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLISTER; CASE REPORT; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG PULSE THERAPY; DRUG TOLERABILITY; EPITHELIZATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; SKIN IRRITATION; SKIN MANIFESTATION; SWEAT GLAND DISEASE;

CHOLINERGIC AGENTS; DOUBLE-BLIND METHOD; EPITHELIUM; GELS; HUMANS; PEMPHIGUS; PILOCARPINE; PLACEBOS;

EID: 33745952031     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02766.x     Document Type: Article

References (27)

1. Burge SM. Intraepidermal immunobullous disease. In: Champion RH, Burton JL, Burns DA, et al., eds. Rook Textbook of Dermatology, 6th edn. Oxford: Blackwell Publishing Ltd, 1998: 1847-1865.
2. Anhalt GJ. Pemphigus vulgaris and the pemphigus disease spectrum. In: Arndt KA, Leboit PE, Rpbinson JK, et al., eds. Cutaneous Medicine and Suegery, 1st edn. Philadelphia: WB Saunders, 1996: 651-679.
3. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: A 20-year review of 107 patients treated with corticosteroids. Arch Deramatol 1976; 112: 962-970.
4. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 645-652.
5. Grando SA. New approaches to the treatment of pemphigus. J Invest Dermatol 2004; 9: 84-89.
6. Karpati S, Amagai M, Prussick R, et al. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol 1993 July; 122: 409-415.
7. Wolff K, Schreiner E. Ultrastructural localization of pemphigus autoantibodies within the epidermis. Nature 1971; 229: 59-61.
8. Bedane C, Prost C, Thomine E, et al. Binding of autoantibodies is not restricted to desmosomes in pemphigus vulgaris: Comparison of 14 cases of pemphigus vulgaris and 10 cases of pemphigus foliaceus studied by western immunoblot and immunoelectron microscopy. Arch Dermatol Res 1996; 288: 343-352.
9. Ablin RJ, Bronson P, Beutner EH. Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol 1969; 13: 321-329.
10. Shu SY, Beutner EH. Isolation and characterization of antigens reactive with pemphigus antibodies. J Invest Dermatol 1973; 61: 270-276.
11. Miyagawa S, Hojo T, Ishii H, et al. Isolation and characterization of soluble epidermal antigens reactive with pemphigus antibodies. Acta Derm Venereol 1977; 57: 7-13.
12. Diaz LA, Patel H, Calvanico NJ. Isolation of pemphigus antigen from human saliva. J Immunol 1980; 124: 760-765.
13. Murahata RI, Ahmed AR. Partial purification and characterization of pemphigus-like antigens in urine. Arch Dermatol Res 1983; 275: 118-123.
14. Peterson LL, Wuepper KD. Isolation and purification of a pemphigus vulgaris antigen from human epidermis. J Clin Invest 1984; 73: 1113-1120.
15. Acosta E, Ivanyi L. Identification of pemphigus-like antigens expressed by SCaBER cells. Br J Dermatol 1985; 112: 157-164.
16. Lyubimov H, Goldshmit D, Michel B, et al. Pemphigus-identifying the autoantigen and its possible induction of epidermal acantholysis via Ca 2+ signalling. Isr J Med Sci 1995; 31: 42-48.
17. Joly P, Gilbert D, Thomine E, et al. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus. J Invest Dermatol 1997; 108: 469-475.
18. Mohimen A, Narula M, Ruocco V, et al. Presence of the autoantibody in healthy relatives of Italian patients with pemphigus vulgaris. Arch Dermatol Res 1993; 285: 176-177.
19. Amagai M, Karpati S, Prussick R, et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90: 919-926.
20. Allen E, Yu QC, Fuchs E. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 1996; 133: 1367-1382.
21. Koch PJ, Mahoney MG, Ishikawa H, et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997; 137: 1091-1102.
22. Montagutelli X, Lalouette A, Boulouis HJ, et al. Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus. J Invest Dermatol 1997; 109: 324-328.
23. Nguyen VT, Lee TX, Ndoye A, et al. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998; 134: 971-980.
24. Grando SA, Dahl MV. Activation of keratinocyte muscarinic acetylcholine receptors reverses pemphigus acantholysis. J Eur Acad Dermatol Venereol 1993; 2: 72-86.
25. Nguyen VT, Arredondo J, Chernyavsky AI, et al. Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 2004; 140: 327-334.
26. Swanson DL, Dahl MV. Methylprednisolone inhibits pemphigus acantholysis in skin cultures. J Invest Dermatol 1983; 81: 258-260.
27. Nguyen VT, Arredondo J, Chernyavsky A, et al. Pemphigus vulgaris IgG (PVIgG) and a corticosteroid exhibit reciprocal effects on keratinocyte adhesion molecules. J Biol Chem 2004; 279: 2135-2146.